GlassScriptPhysician profile
James Mastin Farmer
NPI 1013988161
$7,603.77
in general payments reported to CMS, 2019-2025
12 companies · $1,286 in 2025
The $1,286 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,738 · 2020: $124 · 2021: $277 · 2022: $996 · 2023: $3,014 · 2024: $169 · 2025: $1,286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,466 · Food and Beverage: $1,002.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,466.43 |
| Food and Beverage | $1,002.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $2,917.51 | 2023-2025 | Iovera, Exparel, Zilretta |
| Stryker Corporation | $1,833.37 | 2019-2025 | Aequalis Perform, Aequalis Ascend Flex, Blueprint Patient Specific Instrumentation |
| Medical Device Business Services, INC. | $1,416.36 | 2019-2022 | |
| Depuy Synthes Sales INC. | $1,140.31 | 2019-2025 | Orthovisc, Monovisc, Fibulink |
| Zimmer Biomet Holdings, INC. | $135.44 | 2021-2025 | Juggerknotless Soft Anchor |
| Vertex Pharmaceuticals Incorporated | $30.09 | 2025 | |
| Trice Medical, INC. | $26.79 | 2023 | |
| Si-Bone, INC. | $26.47 | 2023 | |
| Kerecis Limited | $25.40 | 2021 | |
| Kci USA, INC. | $22.42 | 2020 | |
| Bioventus LLC | $16.56 | 2022 | |
| Arthrosurface Incorporated | $13.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Farmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.